Consorci Hospitalari Parc Tauli de Sabadell

Sabadell 08208

0 studies enrolling now · 2 studies all time

What they study most

Follicular Lymphoma, Marginal Zone Lymphoma, UC (Urothelial Cancer)

Studies at this site

• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307) — Completed